Gotthardt M, Schipper M, Franzius C, Béhé M, Barth A, Schurrat T, Höffken H, Gratz S, Joseph K, Behr T M
Department of Nuclear Medicine, Philipps-University of Marburg, Germany.
Nucl Med Commun. 2002 May;23(5):447-52. doi: 10.1097/00006231-200205000-00004.
Persisting perfusion defects may still be found in pulmonary perfusion scintigraphy months or years after pulmonary embolism. The aim of this study was to investigate the rate of persisting perfusion defects and the pattern of scintigraphic follow-up of patients after pulmonary embolism. Only those patients were included into our study who received pulmonary perfusion scintigraphy between 1991 and 1999, and who had perfusion defects including at least one whole segment. These perfusion defects were considered as persisting perfusion defects if unchanged over at least 1 year. From 3640 patients examined, 451 (12.4%) had perfusion defects meeting the criteria of this study. Of those, 129 (28.6%) received a scintigraphic follow-up. In 62 patients (48.1%), a reperfusion of the defects was found. In 38 patients (29.5%), the defects persisted within a follow-up period of up to 12 weeks. However, no pulmonary perfusion scintigraphy was performed thereafter. Out of the 129 patients receiving a scintigraphic follow-up, only 29 (22.5%) had a follow-up over more than 1 year, 19 of those had persisting perfusion defects. It is concluded that our data show an inadequate scintigraphic follow-up of patients with pulmonary embolism which may lead to unnecessary anticoagulant treatment if persisting perfusion defects are misinterpreted as fresh pulmonary embolism. In many cases, there was no further follow-up even if reperfusion of the defects was lacking in early follow-up.
在肺栓塞数月或数年之后,肺灌注闪烁扫描中仍可能发现持续存在的灌注缺损。本研究的目的是调查肺栓塞患者中持续存在的灌注缺损发生率以及闪烁扫描随访模式。只有那些在1991年至1999年间接受肺灌注闪烁扫描且存在包括至少一个整段的灌注缺损的患者才被纳入我们的研究。如果这些灌注缺损至少1年未发生变化,则被视为持续存在的灌注缺损。在3640例接受检查的患者中,451例(12.4%)存在符合本研究标准的灌注缺损。其中,129例(28.6%)接受了闪烁扫描随访。在62例患者(48.1%)中,发现缺损有再灌注。在38例患者(29.5%)中,缺损在长达12周的随访期内持续存在。然而,此后未再进行肺灌注闪烁扫描。在接受闪烁扫描随访的129例患者中,只有29例(22.5%)接受了超过1年的随访,其中19例存在持续的灌注缺损。得出的结论是,我们的数据表明对肺栓塞患者的闪烁扫描随访不足,如果将持续存在的灌注缺损误判为新鲜肺栓塞,可能会导致不必要的抗凝治疗。在许多情况下,即使早期随访中缺损缺乏再灌注,也没有进一步的随访。